The IYD Gene Thyroid dyshormonogenesis type 4 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the IYD gene, which are associated with thyroid dyshormonogenesis type 4. This condition is a rare form of congenital hypothyroidism characterized by the thyroid gland's inability to synthesize thyroid hormones properly due to defects in iodide metabolism. Individuals with this condition may exhibit symptoms such as growth retardation, developmental delays, and various metabolic abnormalities from birth or early infancy.
DNA Labs UAE provides this test at a cost of 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the IYD gene. The results can offer crucial information for the diagnosis, management, and treatment planning for affected individuals, as well as genetic counseling for families. This test is essential for early detection and intervention, which can significantly improve the quality of life and developmental outcomes for those with thyroid dyshormonogenesis type 4.
The DUOXA2 gene plays a critical role in the synthesis of thyroid hormones, which are crucial for regulating metabolism, growth, and development. Mutations in the DUOXA2 gene can lead to thyroid dyshormonogenesis type 5, a condition characterized by an inability of the thyroid gland to produce hormones properly, resulting in congenital hypothyroidism. Early diagnosis and treatment are essential to prevent developmental delays and other serious complications.
The genetic test for thyroid dyshormonogenesis type 5, focusing on the DUOXA2 gene, is a sophisticated diagnostic tool available at DNA Labs UAE. This test is specifically designed to identify mutations in the DUOXA2 gene that are responsible for the condition. It is a crucial step in confirming the diagnosis, enabling personalized treatment plans and informing family planning decisions.
The cost of the DUOXA2 gene thyroid dyshormonogenesis type 5 genetic test is 4400 AED. Conducted at DNA Labs UAE, this test represents a significant advancement in the field of genetic diagnostics, offering hope and clarity for affected individuals and their families. By pinpointing the genetic basis of the condition, healthcare providers can tailor interventions more effectively, improving outcomes for those with this form of congenital hypothyroidism.
The DUOX1 Gene Thyroid dyshormonogenesis type 6 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the DUOX1 gene, which are associated with thyroid dyshormonogenesis type 6. This condition is a rare form of congenital hypothyroidism, characterized by an inability of the thyroid gland to produce thyroid hormones properly due to defects in the hydrogen peroxide generation system necessary for thyroid hormone synthesis. The test plays a crucial role in early diagnosis and management of the condition, enabling targeted treatment strategies to mitigate symptoms and prevent developmental delays associated with untreated hypothyroidism.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test involves analyzing the patient's DNA to identify mutations in the DUOX1 gene. With a cost of 4400 AED, the test is accessible to those who suspect they might have or are carriers of the condition, and it provides essential information for families considering future pregnancies. Early detection through this genetic test can significantly impact the quality of life for individuals with thyroid dyshormonogenesis type 6, offering a pathway to appropriate treatment and management of the condition.
The DUOX2 gene plays a critical role in thyroid hormone biosynthesis, and mutations in this gene can lead to thyroid dyshormonogenesis type 6, a condition characterized by congenital hypothyroidism. This condition arises from the thyroid gland's inability to produce sufficient thyroid hormones, which are crucial for regulating metabolism, growth, and development. Early detection and treatment are vital to prevent intellectual disability and growth failure associated with untreated congenital hypothyroidism.
The genetic test for thyroid dyshormonogenesis type 6 focuses on identifying mutations in the DUOX2 gene. This test is crucial for confirming the diagnosis, understanding the genetic basis of the condition, and guiding treatment decisions. It can also provide valuable information for family planning and genetic counseling.
At DNA Labs UAE, the test for the DUOX2 gene mutation is available, with the cost being 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the DUOX2 gene. The test is performed with high accuracy, and results are typically available within a few weeks. This information is essential for the proper management and treatment of individuals with thyroid dyshormonogenesis type 6, enabling them to lead healthier lives.
The SECISBP2 gene plays a crucial role in thyroid hormone metabolism, which is pivotal for regulating metabolism, growth, and development. Abnormalities in this gene can lead to various health issues, including thyroid hormone metabolism disorders. The genetic test for the SECISBP2 gene is designed to identify mutations or alterations that might affect thyroid hormone production and function. This test is particularly valuable for individuals experiencing symptoms related to thyroid dysfunction or those with a family history of thyroid-related disorders.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the SECISBP2 gene. With a cost of 4400 AED, the test is conducted using advanced genetic sequencing technologies to ensure high accuracy and reliability of results. This test is crucial for the early detection of potential thyroid hormone metabolism abnormalities, enabling timely intervention and management to mitigate health complications associated with such genetic disorders.
The THRB gene thyroid hormone resistance genetic test is a specialized diagnostic tool designed to identify mutations in the THRB gene, which can lead to thyroid hormone resistance. This condition is characterized by the body's inability to respond adequately to thyroid hormones, potentially resulting in various symptoms including developmental delays, abnormal growth, and metabolic issues. The test involves analyzing the patient's DNA to detect any genetic anomalies in the THRB gene that could impair thyroid hormone function.
Offered by DNA Labs UAE, the test is available for a cost of 4400 AED. Conducting this test can be crucial for individuals showing symptoms of thyroid hormone resistance or for those with a family history of thyroid disorders. Early detection through this genetic test allows for a better understanding of the condition, enabling healthcare providers to tailor treatment plans more effectively to manage symptoms and improve the patient's quality of life.
The HADHB gene trifunctional protein deficiency genetic test is a specialized diagnostic procedure aimed at detecting mutations in the HADHB gene, which is crucial for the proper functioning of the mitochondrial trifunctional protein complex. This complex plays a vital role in the breakdown and processing of long-chain fatty acids, a key energy source for the body. Deficiencies in this protein can lead to a range of metabolic disorders, including the severe condition known as trifunctional protein deficiency. This condition can manifest with symptoms such as muscle weakness, cardiomyopathy, hypoglycemia, and liver dysfunction, often presenting in infancy or early childhood.
The genetic test involves analyzing the patient's DNA, usually extracted from a blood sample, to identify any mutations in the HADHB gene that may disrupt the normal function of the trifunctional protein. Early detection through genetic testing is crucial for managing symptoms, preventing complications, and improving the quality of life for affected individuals.
The cost of the HADHB gene trifunctional protein deficiency genetic test is 4400 AED. This test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and laboratory technicians, ensuring accurate and reliable test results. Patients and healthcare providers considering this test are encouraged to contact DNA Labs UAE for more information on the procedure, preparation, and any follow-up consultations that may be necessary based on the test results.
The "CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CRB2 gene, which are known to cause a rare genetic disorder characterized by brain ventriculomegaly (a condition where the brain's ventricles are abnormally enlarged) and cystic kidney disease. This test is crucial for individuals with a clinical history or family history of these conditions, providing them with a definitive diagnosis. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the CRB2 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify these mutations. Early detection through this genetic test can significantly impact the management and treatment options for affected individuals, offering them a better quality of life.
The "ROBO2 Gene Vesicoureteral Reflux Type 2 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the ROBO2 gene, which are associated with Vesicoureteral Reflux (VUR) Type 2. VUR is a condition where urine flows backward from the bladder to the kidneys, potentially leading to kidney damage. This genetic test is crucial for individuals with a family history of VUR or those showing symptoms, as early detection can guide appropriate treatment strategies and prevent complications.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the ROBO2 gene to pinpoint any genetic anomalies linked to the condition. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab using advanced genetic sequencing technologies.
The cost of the test is set at 4400 AED, reflecting the intricate process of genetic analysis and the specialized expertise required to interpret the results. Obtaining a clear genetic insight into VUR Type 2 can be invaluable for affected individuals and their families, offering a pathway to personalized management of the condition and potentially reducing the risk of severe kidney damage.
The SOX17 Gene Vesicoureteral Reflux Type 3 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SOX17 gene, which are linked to Vesicoureteral Reflux (VUR) Type 3, a condition characterized by the abnormal flow of urine from the bladder back into the ureters or kidneys. This genetic predisposition can lead to recurrent urinary tract infections and potential kidney damage if left undiagnosed or untreated. The test is particularly crucial for individuals with a family history of VUR or those showing clinical symptoms of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the SOX17 gene. The process is highly accurate, providing essential information for the early detection, management, and possible prevention of complications associated with Vesicoureteral Reflux Type 3.
The cost of the SOX17 Gene Vesicoureteral Reflux Type 3 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive analysis and detailed report provided by the lab, offering invaluable insights for affected individuals and their healthcare providers to make informed decisions about treatment and management strategies.
